SYNPHORA AB has a total of 51 patent applications. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), Sweden and Australia. Its main competitors in its focus markets pharmaceuticals and machines are VEPEX KFT, BIOGEN IDEC INTERNAT GMBH and DOT KK.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Sweden | 9 | |
#3 | Australia | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Canada | 6 | |
#6 | United States | 4 | |
#7 | New Zealand | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Japan | 1 | |
#12 | Mexico | 1 | |
#13 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Stjernschantz Johan | 39 |
#2 | Resul Bahram | 35 |
#3 | Rask-Andersen Helge | 13 |
#4 | St Jernschantz Johan | 4 |
#5 | Jernschantz Johan St | 2 |
#6 | Jernschantz Johan | 1 |
#7 | Jernschantz H Rask-Andersen J | 1 |
#8 | Johan Stjernschantz | 1 |
#9 | Stjernschaniz John | 1 |
Publication | Filing date | Title |
---|---|---|
EP1986666A1 | Novel method and compositions for treatment of tinnitus | |
WO2006019353A1 | Composition and method for the treatement of psoriasis | |
CA2467410A1 | Method for treatment of glaucoma and ocular hypertension with prostaglandin analgoues without melanogenic side-effect | |
BR0206568A | New Method and Compositions for Local Treatment of Meniere's Disease, Tinnitus and / or Hearing Loss | |
AU6452201A | Methods and compositions for the prevention of myopia | |
AU3340200A | Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula | |
AU2139600A | Method and composition for treatment of female sexual dysfunction | |
AU1435000A | Method for preventing increased iridial pigmentation during prostaglandin treatment | |
US6476074B1 | Method and composition for treatment of erectile dysfunction | |
EP0778774A2 | New use of prostaglandins |